Cargando…
Treatment outcomes of mucosal melanoma of head and neck: Efficacy of immune checkpoint inhibitors for advanced disease
BACKGROUND: Head and neck mucosal melanoma (HNMM) is a rare and aggressive subtype of melanoma. HNMM often develops as a recurrent or metastatic disease, and its prognosis is worse than that of cutaneous melanoma. Recent large-scale clinical studies have reported favorable outcomes with immune check...
Autores principales: | Ohshima, Shusuke, Ueki, Yushi, Yokoyama, Yusuke, Takahashi, Takeshi, Shodo, Ryusuke, Yamazaki, Keisuke, Okabe, Ryuichi, Matsuyama, Hiroshi, Togashi, Takafumi, Takatsuka, Sumiko, Takenouchi, Tatsuya, Horii, Arata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112385/ https://www.ncbi.nlm.nih.gov/pubmed/37082097 http://dx.doi.org/10.3389/fsurg.2022.1032626 |
Ejemplares similares
-
Chemoradiotherapy with 3-weekly CDDP 80 mg/m(2) for head and neck squamous cell carcinoma: 5-year survival data from a phase 2 study
por: Otaki, Kohei, et al.
Publicado: (2022) -
Treatment Outcome of External Auditory Canal Carcinoma: The Utility of Lateral Temporal Bone Resection
por: Saijo, Kohei, et al.
Publicado: (2021) -
Treatment Outcomes and the Safety of Chemoradiotherapy With High-Dose CDDP for Elderly Patients With Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Study
por: Omata, Jo, et al.
Publicado: (2021) -
Predicting Cervical Lymph Node Metastasis Following Endoscopic Surgery in Superficial Head and Neck Carcinoma
por: Okabe, Ryuichi, et al.
Publicado: (2022) -
Head and neck small-cell carcinoma: A multicenter study of 39 cases from 10 institutions
por: Matsuyama, Hiroshi, et al.
Publicado: (2022)